Magic mushroom extracts in lipid membranes

Area of Science:

• Neuroscience
• Biophysics
• Pharmacology

Background:

• Psilocin, the active compound in magic mushrooms, is being investigated for therapeutic uses in nicotine addiction and depression.
• While psilocin is thought to bind to serotonin 5-HT2A receptors, alternative mechanisms are being explored.
• Membrane-mediated receptor desensitization is a potential mechanism for psilocin's effects.

Purpose of the Study:

• To compare the effects of psilocin and serotonin on lipid membrane properties.
• To investigate the role of the chemical structure (tertiary vs. primary amine) in membrane interactions.
• To explore potential membrane-mediated mechanisms of action for psilocin.

Main Methods:

• Molecular dynamics simulations were used to model interactions between psilocin/serotonin and lipid membranes.
• Calorimetry was employed to measure the impact of these compounds on membrane properties.
• Zwitterionic and anionic lipid membranes were utilized to assess varying membrane compositions.

Main Results:

• Both psilocin and serotonin partition to lipid membranes, inducing membrane thinning.
• Psilocin's tertiary amine limits its membrane impact compared to serotonin's primary amine, despite higher partitioning.
• Calorimetry confirmed a melting point depression effect, similar to anesthetics, for both compounds.

Conclusions:

• The findings support a membrane-mediated mechanism for psilocin and serotonin binding.
• Subtle chemical differences, like amine structure, significantly influence psychedelic compound membrane interactions.
• This research provides physical insights into the interaction of psilocin with biological membranes, relevant to its therapeutic applications.